News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Talha Badar: Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
Photo of Talha Badar from mayoclinic.org
Aug 21, 2023, 17:03

Talha Badar: Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.

Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, recently tweeted:

“Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity: article link.

DDX41 GPS is commonly associated with hypocellular marrow and advanced myeloid neoplasm. Uniquely, manifest in older age.”

Talha Badar: Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.

Source: Talha Badar / Twitter

 

cancer DDX41 Mayo Clinic Comprehensive Cancer Center myeloid neoplasms OncoDaily Oncology Talha Badar
Special Coverage
Insight
Dec 30, 2024, 12:39
When Diversity Goals Meet Multiregional Trials by Gautam Mehta et al. - FDA Oncology
Blog
Dec 30, 2024, 12:36
Jean Kaseya: No one serving humanity should endure violence
Insight
Dec 30, 2024, 12:33
Patrick Hwu: Why treating neurological disorders like brain tumors is difficult
Insight
Dec 30, 2024, 12:29
Laura Bukavina: No significant link was found between plant-based or animal-based protein intake and bladder cancer risk
Science
Dec 30, 2024, 12:25
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer
Science
Dec 30, 2024, 12:08
Nicholas Short: Measurable residual disease monitoring in AML
Blog
Dec 30, 2024, 12:06
Michael Hofman: Honoring Felix Feng
Science
Dec 30, 2024, 12:03
Misty Dawn Shields: Rare lung cancers have a paucity of info and they aren’t in first place
Science
Dec 30, 2024, 11:56
Anirban Maitra: The highest cited publication overall is a review on Pancreatic Cancer
Insight
Dec 30, 2024, 11:25
Shane Jacobson: The V Foundation is launching a search for Senior (executive) Leadership Team
Insight
Dec 30, 2024, 11:19
Anirban Maitra: An Open Access review on current status of KRAS inhibitors, resistance drivers and potential combinations
Insight
Dec 30, 2024, 11:16
Filippo Alongi: Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification